Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis

BMC Medicine
15 January  2019
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1242-0

The Benefits of Low Dose Naltrexone

JewishLink
21 May 2020
https://jewishlink.news/monthly-sections/health-link-new/37942-the-benefits-of-low-dose-naltrexone

Ulrich Lanius, PhD and Galyn Forster, MS, LPC - Opioid Antagonists and Traumatic Brain Injury (2017 Conference) (LDN, low dose naltrexone)

They begin their presentation by discussing Naltrexone and seizure activity, as demonstrated through clinical trials. They found that later dosage adjustments were helpful in reducing the cognitive effects.

Leonard Weinstock, MD - Inflammatory Bowel Disease II (2017 Conference) (LDN, low dose naltrexone)

Inflammatory bowel disease is a condition that we see as gastroenterologists on a daily basis. I'm Dr. Weinstock. I'd like to review inflammatory bowel disease, what the traditional approaches are, and some of the newer changes that we've seen with low dose naltrexone. Here are my disclosures.

Raven from the US Crohn’s Disease, MS, Spondylitis and Lyme Disease (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Raven and from the United States has been diagnosed with Crohn's Disease, Multiple Sclerosis, Spondylitis, and Lymes Disease.